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Hedgehog Signaling Is Required for Adult







Studies with embryonic explants and embryonic stem
cells have suggested a role for Hedgehog (Hh) signal-
ing in hematopoiesis. However, targeted deletion of
Hh pathway components in the mouse has so far
failed to provide in vivo evidence. Here we show that
zebrafish embryos mutant in the Hh pathway or
treated with the Hh signaling inhibitor cyclopamine
display defects in adult hematopoietic stem cell
(HSC) formation but not in primitive hematopoiesis.
Hh is required in the trunk at three consecutive
stages during vascular development: for the medial
migration of endothelial progenitors of the dorsal
aorta (DA), for arterial gene expression, and for the
formation of intersomitic vessel sprouts. Interference
with Hh signaling during the first two stages also in-
terferes with HSC formation. Furthermore, HSC and
DA formation also share Vegf and Notch require-
ments, which further distinguishes them from primi-
tive hematopoiesis and underlines their close rela-
tionship during vertebrate development.
Introduction
In vertebrate embryos, hematopoiesis occurs in two
waves, a primitive or embryonic first wave that gives
rise to mainly primitive erythrocytes, and a second, de-
finitive or adult wave that generates hematopoietic
stem cells (HSCs) that can differentiate into all hemato-
poietic lineages, self-renew, and maintain the blood
system throughout adult life. Primitive hematopoiesis
occurs in the extraembryonic yolk sac (YS) of mamma-
lian and avian embryos, and in the ventral blood island
(VBI) of the frog Xenopus laevis. Formation of the first
HSCs occurs in an intraembryonic site, the aorta-
gonad-mesonephros (AGM) region, in mammals, birds,
and amphibians (Chen and Turpen, 1995; Dieterlen-
Lievre, 1975; Medvinsky and Dzierzak, 1996). Lineage
tracing has shown that the primitive and definitive
blood cells of the frog embryo stem from different blas-
tomeres of the 32-cell stage embryo, suggesting that
embryonic and adult blood cells experience very dif-
ferent molecular programming during embryogenesis
(Ciau-Uitz et al., 2000).
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cliffe Hospital, Oxford, OX3 9DS, United Kingdom.phibian VBI, blood and endothelial cells (ECs) derive
from mesoderm and are believed to share a common
bipotential progenitor, the hemangioblast (Keller, 2001;
Walmsley et al., 2002). Direct evidence for its existence
comes from in vitro studies of embryonic stem (ES) cell
cultures (Choi et al., 1998), but in vivo confirmation is
still missing. Definitive adult blood cells, including
HSCs, first arise in the AGM region where clusters of
blood progenitors are attached to the ventral wall of the
dorsal aorta (DA) (Ciau-Uitz et al., 2000; Dieterlen-
Lievre and Martin, 1981; Garcia-Porrero et al., 1995;
Tavian et al., 1996). The clusters, the ventral endothe-
lium, and the underlying mesenchyme express the tran-
scription factor Runx1 (North et al., 1999), and HSC ac-
tivity is found in the runx1+ fraction of AGM cells (North
et al., 2002). Loss of runx1 eliminates cluster formation
in the DA (North et al., 1999), HSC activity (Cai et al.,
2000), and fetal liver hematopoiesis (Okuda et al., 1996;
Wang et al., 1996). Lineage tracing experiments in the
chick embryo have suggested that endothelial cells of
the DA secondarily become hemogenic and give rise to
the clusters (Jaffredo et al., 1998). Alternatively, hemato-
poietic clusters could arise from adult hemangioblasts
localized in the ventral lining of the vessel or in the un-
derlying mesenchyme (Godin and Cumano, 2002).
Little is known about the molecular programming of
definitive hematopoiesis and how it differs from that of
primitive hematopoiesis. Murine explant and ES cell
studies have suggested a role for Hedgehog (Hh) sig-
naling in hematopoiesis. First, anterior epiblast tissue
that normally forms neural ectoderm can be induced
by posterior visceral endoderm to differentiate into the
mesodermal derivatives, blood, and endothelium. In-
dian Hedgehog (Ihh), which is expressed by visceral en-
doderm, can substitute for visceral endoderm in this
induction, and addition of Hh antibodies to the epi-
blast-visceral endoderm explant cocultures prevents
formation of blood and ECs (Dyer et al., 2001). Second,
embryoid bodies differentiated in vitro from ES cells
that lack Ihh or Smoothened (Smo), a transmembrane
protein that is essential for transduction of Hh activity,
or have been treated with Hh signaling inhibitors fail to
form any hematopoietic cells (Byrd et al., 2002; Maye et
al., 2000). By contrast, targeted deletion of Hh pathway
components in the mouse has so far failed to provide
convincing evidence for Hh’s involvement in hemato-
poiesis (Bitgood et al., 1996; Byrd et al., 2002; Chiang
et al., 1996). Functional redundancy of Hh proteins and
the premature death of smo−/− embryos make it difficult
to examine Hh’s involvement in definitive hemato-
poiesis.
In zebrafish embryos, two bilateral populations of
hemangioblast-like cells give rise to primitive blood and
ECs: an anterior population that generates the head
vasculature and primitive myeloid cells, and a posterior
population that forms the axial vessels of the trunk and
tail, the DA and the posterior cardinal vein (PCV), and
primitive erythrocytes (Fouquet et al., 1997; Gering et
al., 1998; Herbomel et al., 1999). The primitive red blood
cells (RBCs) and trunk/tail ECs, which originate from
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390the posterior lateral mesoderm (PLM), migrate into the f
bmidline to form the intermediate cell mass (ICM) that
is flanked dorsally by the notochord and hypochord, c
pventrally by the endoderm and laterally by the somites
(Figure 1A). At the 10 somite stage (14 hpf; hours post- pFigure 1. Runx1+ Putative Definitive Blood Cells Are a Subpopulation of the Dorsal Aorta Endothelial Progenitors that Lie above the Primitive
Erythrocytes in Zebrafish
(A) Schematic diagram of early blood and endothelial development in the trunk of zebrafish embryos. E, endoderm; HC, hypochord; ICM,
intermediate cell mass; NC, notochord; NP, neural plate; PCV, posterior cardinal vein; PLM, posterior lateral mesoderm; SPM, somitic paraxial
mesoderm. (B) Localization of runx1+ putative definitive blood cells in the zebrafish embryo. Views in panels a, f, i, l, and m are lateral with
anterior left and dorsal up. Panels b–e, g, h, j, and k show transverse sections through the trunk with dorsal up. (a) At 26 hpf, runx1 is
expressed in the embryonic midline of the trunk and tail (arrow). (b–d) Transverse sections show that cells expressing runx1, c-myb, and
ikaros are associated with the ventral wall of the DA and lie dorsal to the PCV (arrow). White arrows in panel c mark cells of unknown identity
localized below the skin. (e) hrT is expressed in the dorsal wall of the DA (blue arrow) and in intersomitic sprouts (green arrow). (f–k) Before
the onset of blood circulation, runx1+ cells (f and i, purple stain, black arrows) lie dorsal to the bE1+ RBCs (f, red stain) and within the chord
of flk1+ progenitors (i, red stain) of the DA. Consecutive staining of thin sections confirms that runx1+ cells lie above the bE1+ erythrocytes (g
and h) and are a ventral subpopulation (black arrow in k) of the flk1+ DA angioblast chord (white arrow in j). The blue arrow in panel k marks
the runx1−, flk1+ dorsal part of the DA angioblast chord; the green arrows in panels j and k mark an flk1+ primary intersomitic vessel sprout.
(l and m) Runx1 is expressed below the DA at 2 dpf and 3 dpf. Sections are 10 µm in panels b–e, g, and h, and 5 µm in panels j and k.
Counterstain: eosine in panels c and e, nuclear fast red in panel b.ertilization), individual prospective DA angioblasts
egin to migrate medially (Figure 1A, panel b) and to
oalesce to a cord underneath the notochord and hy-
ochord (Figure 1A; Fouquet et al., 1997). The pros-
ective primitive RBCs and the PCV angioblasts follow
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391shortly afterward and come to lie ventral to the DA angi-
oblasts and dorsal of the endoderm (Figure 1A). DA and
PCV cells can already be distinguished by the 7–12 so-
mite stage (13–15 hpf) as small clusters of lineage-
labeled PLM cells that contribute exclusively to either
the DA or the PCV (Zhong et al., 2001). Arterial gene
expression in the DA ECs is controlled by a cascade of
signaling molecules. Hh secreted by the midline struc-
tures (floor plate, notochord, and hypochord) is at the
top of this signaling cascade that includes Vegf and
Notch (Lawson et al., 2002). By 24 hpf, a primitive vas-
cular loop is established and the RBCs enter circulation
through the venous part of the vasculature, leaving a
luminized PCV behind. Shortly before, primary inter-
somitic vessels (pISVs) sprout from the DA (Isogai et
al., 2003). By 24–26 hpf, putative definitive hematopoi-
etic cells are first identified by their expression of runx1
and their close association with the ventral wall of the
DA (Burns et al., 2002; Kalev-Zylinska et al., 2002).
In this study, we locate the first runx1+ definitive
blood cells in zebrafish above the RBCs but within the
chord of DA progenitors prior to the onset of circula-
tion, and confirm that the first functional derivatives of
definitive HSCs, the T lymphocytes in the thymus, are
lost in runx1-depleted embryos. Using Hh-pathway mu-
tants as well as embryos treated with the Hedgehog
signaling inhibitor cyclopamine, we show in an intact
vertebrate embryo that Hh is required for definitive but
not primitive hematopoiesis. Analyzing the timing of the
Hh requirement for DA formation and definitive hemato-
poiesis, we find that definitive hematopoiesis requires
Hh twice, when it is also needed for (1) the migration
and (2) the arterial specification of the DA angioblasts.
Together with a common requirement for Vegf and
Notch, this argues for a very close relationship between
the DA and the first adult blood stem cells, and possibly
for the existence of a common precursor that displays
a molecular program distinct from that of primitive
hematopoietic cells.
Results
Runx1 Expression Labels the First Definitive
Hematopoietic Cells in Zebrafish
Putative Definitive Blood Cells Are a Subpopulation
of the flk1-Expressing Dorsal Aorta Progenitors
At the time when primitive RBCs enter circulation in ze-
brafish embryos, there is a population of cells between
the two axial vessels, the DA and the PCV, that express
several genes associated with definitive hematopoie-
sis, such as runx1, c-myb, and ikaros (Figure 1B, panels
a–d, black arrows). These cells lie opposite the hrT+
(also known as tbx20) ECs that line the dorsal aspect
of the DA (Figure 1B, panel e, blue arrow; Lawson et
al., 2001). Both their association with the ventral wall of
the DA and their gene expression profile suggest that
these are progenitors for the second, definitive or adult
wave of blood formation. Runx1 expression in this re-
gion is first detected just prior to the onset of blood
circulation. At this time, the runx1+ cells lie just above
the bE1-globin-expressing primitive erythroid cells (Fig-
ure 1B, panels f–h, black arrows in panels f and h) and
constitute a ventral subpopulation of the chord of flk1+cells that will form the DA (Figure 1B, panels i–k, black
arrows in panels i and k), raising the possibility that the
definitive blood cells share a common origin with the
endothelial progenitors of the DA, which most likely de-
rive from the flk1+ cells of the PLM.
Runx1 expression, as well as c-myb expression
(Thompson et al., 1998), persists in the ICM over subse-
quent days (Figure 1B, panels l and m). Thus, runx1
expression marks definitive blood progenitors up to the
appearance of the first identifiable definitive blood
cells, the rag1/2- and ikaros-expressing thymocytes, in
the thymus at 4 days postfertilization (dpf) (Willett et al.,
1997, 2001).
Zebrafish runx1 Is Essential for the Formation
of the First T Lymphocytes
In mammals, runx1 is essential for definitive hemato-
poiesis, a role that is conserved in zebrafish. Zebrafish
embryos injected with an ATG morpholino aimed to in-
terfere with runx1 translation initiation display loss of
c-myb+ definitive blood cells at 50 hpf (Kalev-Zylinska
et al., 2002). Using a splice morpholino targeted against
the splice donor site at the end of exon 2, the first cod-
ing exon, we confirmed the loss of definitive blood pro-
genitors in runx1 morphants (Figure 2B). c-myb expres-
sion in the ICM at 50 hpf (data not shown; n = 12/15)
and midline expression of c-myb and ikaros at 30 hpf
was lost (Figure 2B and data not shown; nc-myb = 11/
15, nikaros = 8/15). Unlike injection of high doses (10 ng)
of antisense morpholino, low doses (5 ng) did not in-
terfere with vasculogenesis (n = 16/23), yet were suffi-
cient to dramatically reduce the amount of normal
splice product formed as shown by RT-PCR (Figure 2C).
In morphant embryos with blood circulation, we found
that expression of ikaros (n = 14/20) and rag1 (n = 13/
15) in the thymus at 6 dpf was lost or reduced (Figure
2D), suggesting a loss or substantial reduction in the
number of thymocytes, the first mature product of the
adult blood stem cell that can easily be identified in
zebrafish embryos. Together with previously published
data (Kalev-Zylinska et al., 2002), our results show that
zebrafish runx1 is essential for definitive hematopoiesis
and strongly implicate the runx1+ cells that first appear
in the ICM at 24–26 hpf as the progenitors for the se-
cond, adult wave of hematopoiesis in zebrafish.
Hedgehog Signaling Is Required for Definitive,
but Not Primitive, Hematopoiesis
In order to determine whether Hh signaling plays a role
in hematopoiesis, we examined the formation of primi-
tive erythrocytes and runx1+ definitive blood cells in Hh
pathway mutants and in embryos treated with the Hh
signaling inhibitor cyclopamine. The mutants analyzed
were the sonic-hedgehog (shh) mutant, sonic-you (syu)
(Schauerte et al., 1998), and the slow muscle-omitted
(smu) mutant. The latter lacks the transmembrane pro-
tein Smoothened (Smo), which is essential for all Hh
signaling (Barresi et al., 2000; Chen et al., 2001). Both
mutants retain some residual Hh signaling activity.
In syu mutants, expression and function of Echidna
hedgehog (Ehh) and Tiggy-winkle hedgehog (Twhh) are
initially unaffected by the loss of shh (Schauerte et al.,
1998), while maternal Smo protein allows some early
Hh signaling to occur in smu mutants (Barresi et al.,
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392Figure 2. Morpholino-Mediated Knockdown of runx1 Expression Interferes with the Formation of HSCs and Their T Cell Progeny
(A) The genomic organization of the zebrafish runx1 locus. Seven of the identified 8 exons (2–8) are protein-coding exons, with the runt
homology domain (RHD) in exons 3–5. The morpholino (red arrowhead) was targeted to the splice donor site at the end of exon 2. (B) The
number of ikaros (panels a and b)-expressing cells ventral to the DA was dramatically reduced in morphants at 30 hpf. By contrast, morphants
developed normal numbers of primitive erythroid and myeloid cells that entered blood circulation (data not shown). (C) RT-PCR using primers
in exons 2 and 3 on cDNA made from total RNA isolated from wild-type and morphant embryos (5 ng MO) showed that the correct splice
product was severely reduced in the morphants. RT-PCR of ef1a was used as an internal loading control. The reaction in lane “0” was
performed in the absence of cDNA. Increasing volumes of cDNA (l) programmed the reactions in the following lanes. S, DNA size standard.
(D) In the thymus of runx1-depleted embryos, a reduction of ikaros (panel a, black and red arrows) and rag1 (panel b, black and red arrows)
expression suggested a decreased number of thymocytes. Views of embryos are lateral in (B) with anterior left and dorsal up. Views in (D)
are dorsal with anterior to the center of the panel.2000; Chen et al., 2001). To eliminate all Hh signaling H
ewe used the Smo inhibitor, cyclopamine (Barresi et al.,
2001; Chen et al., 2002). Treatment with 100 µM cyclo- a
rpamine substantially reduces Hh signaling in zebrafish
embryos (Wolff et al., 2003), causes a you-type pheno- u
atype characteristic of embryos deficient in Hh signaling,
and leads to a loss in artery-specific gene expression a
cby DA ECs (Lawson et al., 2002).
To analyze primitive and definitive hematopoiesis in m
Hh-depleted embryos, we examined mutant and cyclo-
pamine-treated embryos for the presence of bE1+ prim- H
iitive erythrocytes and runx1+ definitive blood cells. We
found that Hh-depleted embryos had normal numbers V
Mof bE1+ primitive erythrocytes (Figures 3A–3C, arrows,
nsyu = 9; Brown et al., 2000, nsmu = 4, ncycl. = 18) that T
ostained positive with the hemoglobin stain diaminoflu-
orene (data not shown; n = 15). Even treatment with icycl.
200 µM cyclopamine, which essentially eliminates allh signaling (Wolff et al., 2003), did not affect primitive
rythropoiesis (data not shown; n = 12). By contrast,
ll three types of Hh-depleted embryos had severely
educed numbers of runx1+ definitive blood cells (Fig-
res 3D–3F, arrows; nsyu = 30, nsmu = 7, ncycl. = 15). In
ddition, rag1+ thymocytes were absent in syu embryos
t 5 dpf (Figures S1A and S1B, n = 8). Thus, we con-
lude that Hh signaling is dispensable for primitive he-
atopoiesis, but essential for HSC formation.
edgehog Is Required for Three Consecutive Steps
n Dorsal Aorta Formation and Intersomitic
essel Sprouting
edial Migration of Dorsal Aorta Angioblasts
he finding that definitive hematopoiesis and DA devel-
pment both require Hh signaling is consistent with the
dea spawned by the runx1/flk1 coexpression data that
definitive blood cells and DA ECs might have a com-
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topoiesis Is Dependent on Hedgehog Sig-
naling
Views in all panels are lateral with anterior
left and dorsal top. While the number of bE1+
primitive erythrocytes is unaffected in the
syu (A) and smu (B) mutants, as well as in
cyclopamine-treated embryos (C), the num-
ber of runx1+ definitive blood cells is clearly
reduced in the mutant and treated embryos
(D–F).mon origin, possibly the flk1+ cells of the PLM of the 10
somite stage (14 hpf) embryo. To elucidate when and
why definitive hematopoiesis and DA specification are
disrupted in Hh-depleted embryos, we analyzed flk1
expression in cyclopamine-treated embryos. In em-
bryos treated from the 2- to 8-cell stage, flk1 expres-
sion was normal at the 10 somite stage (14.5 hpf; Fig-
ures 4A, panel a and 4B, panel a, arrows; n = 9),
showing that the formation of the flk1+ cells is Hh inde-
pendent. At later stages, however, these treated em-
bryos displayed increased numbers of flk1+ cells later-
ally (Figures 4A, panels b and c and 4B, panels b and
c, arrows; nBb = 15, nBc = 14) that had failed to migrate
to the midline and to form a separate chord of an-
gioblasts under the notochord/hypochord (Figures 4A,
panel d and 4B, panel d, blue arrow; n = 14). This sepa-
rate angioblast chord is also missing in smu mutants
(Figure 4C, panel a, blue arrow; n = 5). This suggests
that Hh signaling is needed for the medial migration of
DA progenitors.
Interestingly, syu mutants do possess a distinct
chord of DA progenitors in the midline (Figure 4C, panel
b; n = 10), suggesting that Twhh and Ehh are sufficient
to mediate angioblast migration.
To examine the timing of the Hh requirement for an-
gioblast migration, we treated embryos with cyclopam-
ine starting from different time points. We found that
treatment after 90% epiboly (9 hpf; Figure 4D, panel a;
n = 12/17), from the 10 somite stage (14 hpf; Figure 4D,
panel b; n = 15) and from the 15 somite stage (16.5
hpf; Figure 4D, panel c; n = 14) did not interfere with
angioblast migration, though the level of flk1 expres-
sion appeared reduced in embryos that were treated
early in somitogenesis (Figure 4D, panels a and b).
Thus, Hh is needed for angioblast migration before the
end of gastrulation, that is, long before the cells begin
to migrate.
Arterial Gene Expression
In syu mutants, arterial gene expression is lost (Lawson
et al., 2002), although medial migration of angioblasts
occurs (Figure 4C, panel b). This suggested that Hh’srole in arterial specification was separable from its role
in angioblast migration. We therefore analyzed the tim-
ing of the Hh requirement for the expression of the arte-
rial genes ephrinB2a, gridlock (grl), and notch5 (Lawson
et al., 2001). We found that cyclopamine treatments
from the 2- to 8-cell stage (data not shown), 90% epib-
oly (data not shown), or the 10 somite stage (14 hpf)
eliminated all ephrinB2a (Figure 5A, panel a; n = 9/11),
grl (Figure 5A, panel d; n = 20), and notch5 (Figure 5A,
panel h; n = 28) expression at 24 hpf, while treatment
from the 15 somite stage (16.5 hpf) led to only a slight
reduction in the expression of these markers (Figure 5A,
panel b and data not shown; nephrinB2a = 15, ngrl = 15,
nnotch5 = 13). These data show that subsequent to Hh’s
function in medial migration of the flk1+ cells, Hh signal-
ing during early somitogenesis plays a second separate
role in the induction of arterial genes in angioblasts of
the DA.
Hh signaling beyond the 15 somite stage is not
needed for the maintenance of ephrinB2a, gridlock
(grl), and notch5 expression at 24 hpf (Figure 5A, panel
c and data not shown; nephrinB2a = 15/16, ngrl = 15,
nnotch5 = 17). By contrast, hrT, whose expression is re-
stricted to the dorsal wall of the DA, required Hh signal-
ing not only for its induction but also for its mainte-
nance (Figure 5A, panels e–g; ne = 20, nf = 12, ng = 15).
Its expression was lost in all treated embryos, including
those that were treated after hrT expression had al-
ready been induced in DA endothelial cells (Figure 5A,
panels e–g). These results suggest that late Hh signal-
ing from the overlying notochord/hypochord after initia-
tion of DA specification may be required to make the
dorsal aspect of the DA different from the ventral endo-
thelium.
Primary Intersomitic Vessel Sprouting
pISVs sprout bilaterally from the dorsal hrT+ wall of the
DA after 20 hpf (Isogai et al., 2003). These sprouts are
flk1+ (Fouquet et al., 1997), and their formation is hrT
dependent (Szeto et al., 2002). Consistent with the loss
of hrT expression, all embryos treated with cyclopam-
ine from the 15 somite stage (16.5 hpf) failed to show
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394Figure 4. Medial Migration of flk1+ Dorsal
Aorta Progenitors Requires Hedgehog Sig-
naling prior to the End of Gastrulation
Views in (A) panels a–c and (B) panels a–c
are dorsal with anterior top. Views in (A)
panel d, (B) panel d, (C), and (D) are lateral
with anterior left and dorsal top. In control
embryos, syu mutants ([C], panel b) and em-
bryos treated with cyclopamine after 90%
epiboly (9 hpf; [D]) endothelial progenitors
migrate to the midline and form a separate
chord of flk1+ angioblasts (blue arrows in [A],
panel d, [C], and [D]). By contrast, smu mu-
tants and embryos treated prior to the end
of gastrulation display a defect in angioblast
migration and do not develop of separate
chord of flk1+ cells in the midline ([B] and [C],
panel a). Neither mutant nor treated embryos
(B–D) form intersomitic vessels (green ar-
rows in controls; [A, C, and D]).flk1+ sprouts at 24 hpf (Figure 4D, panel c; n = 14), sug- o
ngesting that pISVs are not forming in treated embryos
in which flk1+ cells have reached the midline and ex- c
fpress all arterial genes, except hrT. Thus, pISV forma-
tion is the third step in early vasculo/angiogenesis that t
mhas a temporally distinct Hh requirement.
g
aTiming of Hedgehog Requirement for Definitive
Hematopoiesis Coincides with that for the Migration
and Arterial Specification of the Dorsal D
RAorta Angioblasts
To determine the timing of the Hh requirement for defin- D
pitive hematopoiesis and to compare it to that in vas-
culo/angiogenesis of the DA, we repeated the same o
acyclopamine treatments to analyze runx1 expression.
As shown above, embryos treated from the 2- to 8-cell c
tstage displayed a severe reduction in the number of
runx1+ definitive blood cells (Figures 3F and 5B, panel a
ia; n = 15). Similarly, embryos treated from 90% epiboly
(9 hpf, n = 15) and the 10 somite stage (14 hpf, n = 9) e
(showed reduced numbers of runx1+ cells (Figure 5B,
panels b and c). Only if the treatment was performed a
tafter the 15 somite stage were almost normal numbers
of runx1-expressing cells found (Figure 5B, panels d a
band e; nd = 17/20, ne = 12/14). This suggests that the
induction of definitive hematopoiesis requires Hh sig- t
bnaling prior to the 15 somite stage (16.5 hpf). Because
treatment from the 2- to 8-cell stage only up to the endf gastrulation (90% epiboly, 9 hpf; Figure 5B, panel f;
= 15) also eliminates runx1+ cells at 26 hpf, we con-
lude that Hh is needed twice during embryogenesis
or the formation of definitive blood cells. Intriguingly,
he timing of the Hh requirement during definitive he-
atopoiesis coincides with that for programming mi-
ration of the DA angioblasts and for the induction of
rterial gene expression.
efinitive Hematopoiesis-like DA Specification
equires Vegf and Notch Signaling
A progenitors and runx1+ definitive blood cells ex-
ress the Vegf receptor Flk1. Because the expression
f artery-specific genes is Vegf dependent (Lawson et
l., 2002), it is possible that the formation of the runx1+
ells is also Vegf dependent. To test this, we examined
he Vegf pathway mutant plcg1 (Lawson et al., 2003)
nd applied a Vegf receptor tyrosine kinase (Vegfrtk)
nhibitor (Hennequin et al., 1999) on embryos at 90%
piboly (9 hpf). This treatment, like the plcg1 mutation
Lawson et al., 2003), eliminates the expression of the
rterial gene ephrinB2a (Figure 6A; n = 14) and causes
he loss of pISVs (Figure 6B, green arrow). When we
nalyzed hematopoiesis in treated and mutant em-
ryos, we found that the inhibitor and the plcg1 muta-
ion abrogated the formation of the runx1+ definitive
lood cells (Figure 6C; n = 16; Figure 6D;Vegfrtk inh.
nplcg1 = 4), while primitive hematopoiesis, as judged by
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395Figure 5. Hedgehog Requirement for Adult Hematopoiesis Coincides Temporally with that for Medial Migration of and Arterial Gene Expression
in Dorsal Aorta Progenitors
Views of the trunk region of the embryos are lateral with anterior left and dorsal top. (A) Arterial specification requires Hedgehog signaling
during early somitogenesis. Cyclopamine treatment from the 10 somite stage (14 hpf) eliminates the expression of the artery-specific genes
ephrinB2a (a), grl (d), notch5 (h), and hrT (e). Treatments from the 15 somite stage and 20 hpf only weakly affect ephrinB2a expression (b and
c), but completely eliminate hrT expression (f and g), even in embryos in which hrT expression had already been initiated (g, inset). (B)
Hedgehog signaling is required for adult hematopoiesis before the end of gastrulation and during early somitogenesis. Cyclopamine treatment
before the end of gastrulation (a and f) and during early somitogenesis (a–c) severely reduces the number of runx1+ definitive blood cells.
Their number is almost unaffected in embryos treated after the 15 somite stage (16.5 hpf; panels d and e).bE1 expression and diaminofluorene staining, was un-
affected (Figure 6E; nVegfrtk inh.,bE1 = 14, nVegfrtk inh.,DAF =
10; Lawson et al., 2003). Vegfrtk inhibitor-treated em-
bryos also contained no rag1+ thymocytes at 5 dpf (Fig-
ures S1C and S1D, n = 15). Thus, Vegf signaling is
essential for DA specification and definitive hematopoi-
esis, but not for primitive erythropoiesis.
Expression of some arterial genes such as ephrinB2a
by the DA ECs depends on Notch signaling down-
stream of Vegf, as their expression is lost in the mind
bomb (mib) mutant (Figure 6F; n = 10; Lawson et al.,
2001), which lacks a ubiquitin ligase that is essential for
Notch signaling (Itoh et al., 2003). To find out whether
the runx1+ cells had a similar Notch requirement, we
examined runx1 expression in mib embryos. In these
mutant embryos, which do form an angioblast chord
with pISV sprouts (Figure 6G; n = 5), runx1 expression
was lost (Figure 6H; n = 9) while bE1 expression was
normal (Figure 6J; n = 7). Consistent with the loss of
definitive blood cells, later embryos contained no rag1+thymocytes (Figures S1E and S1F, n = 6). Similarly,
treatment of embryos with the γ-secretase inhibitor,
DAPT, which when applied from sphere stage (4.3 hpf)
causes somitic and neuronal defects that are typical of
Notch-depleted embryos (Geling et al., 2002), elimi-
nated runx1 expression when used from tailbud stage
(Figure 6I; n = 30), but leaves primitive erythropoiesis,
as judged by DAF staining, unaffected (data not shown;
n = 10). Thus, DA and HSC formation not only share Hh
but also Vegf and Notch requirements.
Discussion
Hedgehog Is Required for Definitive,
but Not Primitive, Hematopoiesis
Our data show in an intact vertebrate embryo that de-
finitive but not primitive hematopoiesis requires Hh sig-
naling. A role in primitive hematopoiesis was proposed
by studies on mouse embryonic explants and mouse
ES cells (Byrd et al., 2002; Dyer et al., 2001; Maye et
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Views are lateral with anterior left and dorsal top. Embryos that carry a mutation in the Vegf or Notch signaling pathway or have been treated
with an inhibitor blocking the Vegf or Notch signaling pathway lack expression of the definitive blood marker runx1 (C, D, H, and I), but display
normal expression of the primitive erythroid gene bE1 (E and J). They form an angioblast chord ([B and G], blue arrows), which fails to express
the arterial gene ephrinB2a (A and F). Vegf, but not Notch signaling, is required for angiogenic sprouting of primary intersomitic vessels ([B
and G]; green arrows in [G]).al., 2000), but neither the targeted deletion of any of
tthe Hh ligand genes nor the knockout of the gene that
dencodes the transmembrane protein, Smo, led to a loss
eof primitive hematopoiesis (Bitgood et al., 1996; Byrd
Let al., 2002; Chiang et al., 1996). Thus, our data are con-
fsistent with the mouse knockouts. Whether other sig-
wnals, maternal or embryonic, make Hh signaling dis-
gpensable for primitive hematopoiesis in the embryo, as
(suggested previously (Byrd et al., 2002), will have to be
Naddressed in the future.
pDefinitive hematopoiesis has not been examined in
tHh-depleted mouse embryos. The finding that shh−/−,
wdhh−/−, and half of the ihh−/− embryos survive until birth
t(Bitgood et al., 1996; Byrd et al., 2002; Chiang et al.,
p1996) suggests that definitive hematopoiesis is unaf-
efected in these embryos. However, functional redun-
tdancy of the Hh proteins and the early lethality of the
2smo knockout embryos make it difficult to examine the
(
Hh requirement for definitive hematopoiesis in the mouse.
f
The confirmation in the mouse will have to await a more b
targeted conditional smo knockout. d
p
Vegf Is Essential for Definitive, but Not Primitive, s
Hematopoiesis in Zebrafish t
Mutation in plcg1 and treatment with the Vegfrtk inhibi- i
tor eliminates definitive hematopoiesis in zebrafish em- i
bryos, while primitive hematopoiesis is unaffected. The m
requirement for Vegf in definitive hematopoiesis is con- e
sistent with (1) the expression of the Flk1 receptor by p
the runx1+ definitive blood cells, (2) the inability of flk1−/− (
ES cells to participate in murine fetal liver hematopoie- t
sis and blood cell formation in adult mouse chimeras m
(Shalaby et al., 1997), and (3) the finding that Vegf is
required in an internal autocrine loop to ensure survival N
of hematopoietic stem cells (Gerber et al., 2002). Our P
data show that Vegf signaling is required for the forma- M
dtion of the first definitive blood cells.The lack of a requirement for Vegf in primitive hema-
opoiesis is surprising, given that Vegf, Flk1, and Plcg1
epletion cause severe defects in primitive hematopoi-
sis during mouse embryogenesis (Ferrara et al., 1996;
iao et al., 2002; Shalaby et al., 1995). However, zebra-
ish embryos injected with a vegf morpholino, treated
ith a Vegfrtk inhibitor, or mutated in the flk1 or plcg1
enes, do not display a loss of primitive erythropoiesis
our data and Habeck et al., 2002; Lawson et al., 2003;
asevicius et al., 2000). Furthermore, zebrafish flk1 ex-
ression is different from that of its mouse homolog. In
he mouse, flk1 expression is likely to occur in two
aves. The first wave precedes the expression of the
ranscription factor scl (Chung et al., 2002), is scl inde-
endent (Visvader et al., 1998), and is essential for scl
xpression (Ema et al., 2003). Once scl is expressed,
he second wave may be scl dependent (Kappel et al.,
000). In zebrafish, flk1 is only expressed after scl
Fouquet et al., 1997; Gering et al., 1998), is not needed
or scl expression (Habeck et al., 2002), can be induced
y scl (Gering et al., 1998, 2003), and is clearly depen-
ent on scl, as analysis of flk1 expression in scl mor-
hants shows (Patterson et al., 2005). Altogether, this
uggests that the early wave of flk1 expression and
herefore its role in primitive hematopoiesis, as defined
n the mouse, is not conserved in zebrafish. Yet, even
n the mouse, the Vegf requirement during primitive he-
atopoiesis is not absolute, but conditional, as day 7.5
mbryonic flk1−/− cells and flk1−/− ES cells can, in the
resence of serum, differentiate into blood cells in vitro
Hidaka et al., 1999; Schuh et al., 1999). This suggests
hat other signals can replace Vegf during primitive he-
atopoiesis. The nature of these signals is unknown.
otch Is Needed for Definitive, but Not
rimitive, Hematopoiesis
ib mutants and DAPT-treated zebrafish embryos lack
efinitive but not primitive blood cells, showing in an
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397intact vertebrate embryo that Notch is required for de-
finitive but not primitive hematopoiesis. Our data are
consistent with explant studies in the mouse that dem-
onstrated an essential role for notch1 in the formation
of HSCs in cultured explants of the para-aortic splanch-
nopleura, the mesodermal precursor of the AGM region
(Kumano et al., 2003). Like mib mutants in zebrafish,
mouse notch1 knockout mice form primitive blood nor-
mally. They die early due to angiogenic remodeling de-
fects, thus preventing the analysis of definitive hemato-
poiesis in the intact mouse embryo.
Hedgehog Is Needed at Three Separate Stages
for Dorsal Aorta Development: Angioblast
Migration, Arterial Specification, and Angiogenic
Sprouting of Primary Intersomitic Vessels
Hedgehog was previously shown to be required for the
expression of artery-specific genes by DA ECs (Lawson
et al., 2002). Here, we extend these studies to show
that Hh is also needed independently for the medial
migration of DA progenitors and for angiogenic sprout-
ing of primary ISVs from the DA (Figure 7). It is not re-
quired for the formation of flk1+ cells in the PLM. Using
the Smo inhibitor cyclopamine to analyze the timing
of the Hh requirement, we find that Hh signaling before
the end of gastrulation is required for medial angioblast
migration (Figure 7A). The previous study (Lawson et
al., 2002) did not reveal this early requirement because
the authors applied cyclopamine too late to affect an-
gioblast migration and because functional redundancy
of Hh ligands rescues angioblast migration in the syu
mutant that they examined. Hh’s effect on angioblast
migration is likely to be indirect. First, the source of the
Hh signal, the embryonic midline, is remote from the
PLM (Currie and Ingham, 1996; Ekker et al., 1995;
Krauss et al., 1993). Second, expression of the Hh
target genes ptc1 and ptc2, which encode Hh recep-
tors, is absent in the PLM (Lewis et al., 1999). Candi-Figure 7. Hedgehog Is Involved at Three Distinct Developmental
Stages in Dorsal Aorta and Adult Blood Stem Cell Formation
See Discussion for details.date mediators of the Hh signal are Vegf and semapho-
rin3a1 (sema3a1), whose expression in the somites is
activated and repressed by Hh, respectively, and which
have been implicated as antagonistic players in DA an-
gioblast migration and/or coalescence in the midline
(Cleaver et al., 1997; Lawson et al., 2002; Shoji et al.,
2003). However, neither the zebrafish Vegf pathway mu-
tants examined so far (Habeck et al., 2002; Lawson et
al., 2003) nor the embryos treated with the Vegfrtk in-
hibitor (this study) display a DA angioblast migration
defect as clear as that caused by the loss of Hh signal-
ing. Interestingly, Hh has recently also been shown to
be essential for endothelial chord and tube formation
in avian and murine embryos as well as in EC cultures
(Vokes et al., 2004), suggesting that such a role is con-
served in vertebrate embryos.
During early somitogenesis, Hh is essential for the
initiation of the expression of artery-specific genes
(Figure 7B). In this context, Hh is at the top of a signal-
ing cascade that involves Vegf and Notch (Lawson et
al., 2002). While all arterial genes analyzed (grl, notch5,
hrT, and ephrinB2a) are dependent on Vegf signaling
(our unpublished data), only ephrinB2a and notch5 also
require Notch signaling downstream of Vegf (Lawson et
al., 2002).
Several aspects of the signaling cascade involved in
DA specification in zebrafish are conserved in the
mouse (Rossant and Hirashima, 2003), most notably
the lack of ephrinB2 gene expression in notch1,
rbpsuh, and dll4 single and hey1/hey2 double knockout
mice (Duarte et al., 2004; Fischer et al., 2004; Krebs et
al., 2004), suggesting that the whole pathway is con-
served. Functional redundancy of the Hh ligands and
the early lethality of the smo as well as vegf and flk1
knockout mice have so far prevented examination of
their role in DA specification.
Our data also identified a third stage, during late
somitogenesis, when Hh signaling is required for (1)
pISV sprouting and (2) the expression of hrT (Figure
7C), a gene which marks the dorsal nonhemogenic as
opposed to the ventral hemogenic wall of the DA. While
hrT expression in the dorsal wall is independent of
Notch and requires late Hh signaling, runx1 expression
in the ventral wall displays the inverse signaling require-
ments. Whether the two signals act antagonistically is
currently under investigation.
Adult Blood Stem Cells Are a Subpopulation
of Dorsal Aorta Progenitors
The development of runx1+ definitive blood cells is
closely linked to the formation of the DA. First, runx1+
cells are a subpopulation of the flk1+ cell chord that
forms the DA. Second, the signaling requirements for
the DA and the runx1+ definitive blood cells are very
similar and are clearly distinct from those of primitive
erythrocytes. Unlike primitive erythropoiesis, formation
of the DA and definitive blood needs Hh, Vegf, and
Notch signaling. Hh is required for definitive hemato-
poiesis (1) when Hh is also required for programming
angioblast migration to the midline and (2) when Hh is
essential for arterial gene expression. This suggests at
least that correct arterial specification is required for
definitive hematopoiesis. Together with the flk1-runx1
Developmental Cell
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oMaintenance of Fish Stocks
a
Breeding zebrafish were maintained and embryos were raised and
P
staged according to Westerfield (1993). The mutant alleles used
u
were syut4, smub641, plcg1y10, and mibta52b.
p
G
Treatment of Embryos with Small-Molecule Inhibitors T
Cyclopamine (Toronto Research Chemicals, North York, Ontario, a
Canada; stock solution in DMSO: 12.5 mM) was used in fish facility
water to treat fish embryos at concentrations of 100 and 200 µM.
Cyclopamine treatment is reversible, as previously shown (Wolff et S
al., 2003). Embryos that were treated up to 90% epiboly had their
S
chorions ruptured, and were washed extensively in facility water
c
and allowed to grow up to the point of collection.
The Vegf receptor tyrosine kinase inhibitor catalog number
676475 (Calbiochem, Nottingham, UK; stock solution in DMSO at
A12.5 mM) was tested at concentrations of 2.5, 5, 12.5, and 25 µM
in fish facility water. Treatment of embryos with 2.5 and 5 µM from
T90% epiboly (9 hpf) did not affect the overall phenotype of the em-
Ubryos, while higher concentrations caused shortening of the em-
Cbryonic axis. Therefore, all experiments were done at 5 µM.
aDAPT (Calbiochem; dissolved in DMSO at 12.5 mM) was applied
Sat 100 M as described previously (Geling et al., 2002).
fPregastrula embryos were treated inside the chorion. Ninety per-
tcent epiboly embryos and older embryos had their chorion rup-
ftured or removed prior to treatment. Diaminofluorene staining was
performed as described previously (Weinstein et al., 1996).
R
RNA In Situ Hybridization on Whole Mounts and Sections R
RNA in situ hybridization experiments on whole mounts and sec- A
tions were performed as described previously (Jowett and Yan, P
1996). For double staining of sections, whole-mount double in situ
hybridization was performed with a digoxigenin- and a fluorescein- R
labeled probe. Antibody detection of one of the probes using an
alkaline phosphatase (AP)-conjugated antibody was performed on B
the whole mount using Fast Red (Roche, Welwyn Garden City, UK) s
as the substrate. The enzyme was inactivated by washing the em- t
bryos 4 × 5 min in 0.1 M glycine-HCl (pH 2.2) and fixing them in 4% o
paraformaldehyde overnight. Embryos were washed in 1× PBS + B
0.1% Tween, then embedded in 1.5% agarose with 5% sucrose, (
incubated in 30% sucrose solution overnight, and sectioned at 5 C
or 10 µm on the cryostat. The sections were dried overnight, ex-
Bposed to the second AP-conjugated antibody, washed, and photo-
ngraphed on a Nikon Eclipse E600 fluorescent microscope (Nikon,
6Kingston upon Thames, UK) using a rhodamine filter set, before
BBM purple (Roche) was used to detect the second probe under
Pnormal light. Some embryos were embedded in JB4 (Polysciences,
lWarrington, PA) and sectioned on the microtome (Figure 1B, panels
fb–e). Some sections were counterstained with eosine or nuclear
9fast red (Vector Laboratories, Peterborough, UK).
B
Genomic Sequence Analysis, Morpholino S
Design, and Injection b
The genomic organization of the zebrafish runx1 locus was de- E
duced from a comparison of its cDNA sequence (GenBank acces- B
sion number AB043787) with genomic trace sequences using the Z
BLAST program on the NCBI web site. An antisense morpholino H
(MO; Gene-Tools, Philomath, OR) was designed against the splice m
donor at the end of the second exon and had the sequence 5#-
CAGCGCTCTTACCGTATTTGGCGTCC-3#. The effects of MOs have
abeen shown to be penetrant throughout the first 2 days of develop-
tment (Nasevicius and Ekker, 2000). Increasing volumes (0.1–1 nl) of
mMO (10 ng/nl, dissolved in distilled water) were injected into 1- to
C8-cell stage zebrafish embryos in their chorions.
h
CRT-PCR
RNA was isolated from 100–150 dechorionated embryos using the b
STri-reagent (Sigma, Poole, UK) and cleaned up using the RNAeasyit (Qiagen, Crawley, UK) according to the manufacturer’s instruc-
ions. RNA (1.5 µg) was reverse transcribed in a final volume of 20
l containing 1 mM NTPs, 2.5 mM DTT, 200 ng/µl random 10-mer
rimers, 20 U RNasin (Promega, Southampton, UK), 100 U M-MLV
everse transcriptase (RT), and 1× RT-buffer (Invitrogen, Paisley,
K). Reactions were incubated at 42°C for 90 min. Thirty microliters
f distilled H2O was added and the sample was boiled for 5 min
nd frozen at −20°C. The RT product (0.1–0.8 µl) was used in the
CR for runx1 and ef1a, which was performed in a single tube
sing Jump Start TAQ (Sigma) with the following gene-specific
rimers: runx1: 5#-TCCCCATCCCGAAACTCAC-3#, 5#-AAGGCGAT
GGCAGGGTC-3#, ef1a: 5#-CACCCTGGGAGTGAAACA-3#, 5#-ACT
GCAGGCGATGTGAGC-3#. Eighteen cycles were used for ef1a
nd 30 for runx1.
upplemental Data
upplemental Figure S1 is available at http://www.developmentalcell.
om/cgi/content/full/8/3/389/DC1/.
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